Program
tegacorat
Also written as “GRT6019”, “Tegacorat” and “[14C]GRT6019”.
Its studies are mostly in Muscular Dystrophy, Duchenne, led by Grünenthal.
Furthest: phase 2, since Oct 27, 20264 company-led studies, 1 open or runningNext primary completion: Jan 4, 2030 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Grünenthal | 41 open or running | phase 2since Oct 27, 2026 | Dec 19, 2025 | Jan 4, 2030phase 2 · NCT07911995 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Dec 19, 2025First study: phase 1 study in Muscular Dystrophy, DuchenneFirst studyNCT07317063 · 18 enrolled · United States
- Jan 9, 2026Phase 1 study in Muscular Dystrophy, DuchenneNCT07347548 · 24 enrolled · France
- Mar 13, 2026Phase 1 study in Healthy Male VolunteersNCT07479745 · 10 enrolled · United Kingdom
- Oct 27, 2026Phase 2 study in Muscular Dystrophy, DuchennePhase 2 reachedNCT07911995 · 36 planned
Ahead
- Jan 4, 2030Primary completion: phase 2 study in Muscular Dystrophy, DuchenneNCT07911995
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 4 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07911995Muscular Dystrophy, Duchenne | 2 | Not yet recruiting | Jan 4, 2030 | 36 |
| NCT07479745Healthy Male Volunteers · United Kingdom | 1 | Completed | Jun 18, 2026 | 10 |
| NCT07347548Muscular Dystrophy, Duchenne · France | 1 | Completed | Jun 9, 2026 | 24 |
| NCT07317063Muscular Dystrophy, Duchenne · United States | 1 | Completed | Jan 6, 2026 | 18 |
How it is read
Names in the registry
- “GRT6019”, 2 entries
- “Tegacorat”, 1 entry
- “[14C]GRT6019”, 1 entry
Conditions, from the studies’ own filings
- Muscular Dystrophy, Duchenne, 3 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.